WEKO3
アイテム
{"_buckets": {"deposit": "5089237d-297f-4f68-873d-9e9b30e87a4b"}, "_deposit": {"created_by": 12, "id": "5229", "owners": [12], "pid": {"revision_id": 0, "type": "depid", "value": "5229"}, "status": "published"}, "_oai": {"id": "oai:iwatemed.repo.nii.ac.jp:00005229", "sets": ["35", "80"]}, "author_link": ["19384", "19385"], "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2015-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "21", "bibliographicPageStart": "15", "bibliographicVolumeNumber": "69", "bibliographic_titles": [{"bibliographic_title": "臨床婦人科産科"}]}]}, "item_10001_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "●がんに起こる遺伝子変異には,がんの発生や進展に強くかかわるドライバー変異と,付随的な結果として生じるパッセンジャー変異があり,ドライバー変異を標的とした薬剤では高い奏効率が期待される.●分子標的治療薬として,がん細胞自身に存在する分子だけではなく,がん環境の分子を標的とした創薬も進んでおり,その代表が血管新生阻害薬である.●分子標的薬の使用においてはバイオマーカーの探求とvalidationを念頭におく必要がある.(著者抄録)", "subitem_description_type": "Abstract"}]}, "item_10001_heading_23": {"attribute_name": "見出し", "attribute_value_mlt": [{"subitem_heading_banner_headline": "医学部", "subitem_heading_headline": "産婦人科学", "subitem_heading_language": "ja"}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0386-9865", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "小島, 淳美"}], "nameIdentifiers": [{"nameIdentifier": "19384", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "杉山, 徹"}], "nameIdentifiers": [{"nameIdentifier": "19385", "nameIdentifierScheme": "WEKO"}]}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "*シグナルトランスダクション", "subitem_subject_scheme": "Other"}, {"subitem_subject": "*抗腫瘍剤(治療的利用)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "モノクローナル抗体(治療的利用)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Epidermal Growth Factor Receptor(拮抗物質・阻害物質)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "*生殖器腫瘍-女性(薬物療法)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "組換え融合タンパク質(治療的利用)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "MAP Kinase Kinases(拮抗物質・阻害物質)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "c-akt癌原遺伝子タンパク質(拮抗物質・阻害物質)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "新薬開発", "subitem_subject_scheme": "Other"}, {"subitem_subject": "B-raf癌原遺伝子タンパク質(拮抗物質・阻害物質)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Protein Kinase Inhibitors(治療的利用)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Vascular Endothelial Growth Factor A", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Phosphatidylinositol 3-Kinases", "subitem_subject_scheme": "Other"}, {"subitem_subject": "*分子標的治療", "subitem_subject_scheme": "Other"}, {"subitem_subject": "TOR Serine-Threonine Kinases(拮抗物質・阻害物質)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Trebananib(治療的利用)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ヒト", "subitem_subject_scheme": "Other"}, {"subitem_subject": "女", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "【ゲノム時代の婦人科がん診療を展望する-がんの個性に応じたpersonalizationへの道】 婦人科がんのシグナル解析と分子標的治療の未来", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "【ゲノム時代の婦人科がん診療を展望する-がんの個性に応じたpersonalizationへの道】 婦人科がんのシグナル解析と分子標的治療の未来"}]}, "item_type_id": "10001", "owner": "12", "path": ["35", "80"], "permalink_uri": "https://iwatemed.repo.nii.ac.jp/records/5229", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-03-17"}, "publish_date": "2015-03-17", "publish_status": "0", "recid": "5229", "relation": {}, "relation_version_is_last": true, "title": ["【ゲノム時代の婦人科がん診療を展望する-がんの個性に応じたpersonalizationへの道】 婦人科がんのシグナル解析と分子標的治療の未来"], "weko_shared_id": 12}
【ゲノム時代の婦人科がん診療を展望する-がんの個性に応じたpersonalizationへの道】 婦人科がんのシグナル解析と分子標的治療の未来
https://iwatemed.repo.nii.ac.jp/records/5229
https://iwatemed.repo.nii.ac.jp/records/522962e4c9ff-6076-427f-90c4-d43488b5e72c
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-03-17 | |||||
タイトル | ||||||
タイトル | 【ゲノム時代の婦人科がん診療を展望する-がんの個性に応じたpersonalizationへの道】 婦人科がんのシグナル解析と分子標的治療の未来 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
小島, 淳美
× 小島, 淳美× 杉山, 徹 |
|||||
書誌情報 |
臨床婦人科産科 巻 69, 号 1, p. 15-21, 発行日 2015-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0386-9865 | |||||
見出し | ||||||
大見出し | 医学部 | |||||
小見出し | 産婦人科学 | |||||
言語 | ja |